Vetter Pharma Produktionsmitarbeiter - Werde Teil des Teams

Aseptic filling and packaging for dynamic drug innovators

 

Your strategic injectables CDMO for Asia’s evolving market

Asia’s biotech and pharmaceutical companies are rapidly emerging as global market leaders. As a globally acting Contract Development and Manufacturing Organization (CDMO), Vetter is proud to partner these businesses in their efforts to advance their innovative new drug therapies. See how we can support you and your products at every step from early-stage clinical development to commercial manufacturing.
Please accept marketing-cookies to watch this video.

WHY WORK WITH VETTER

VALUE ADDING PARTNERSHIP

The distinctive, globally recognized quality of our services can set you and your product apart on the world market.

PROVEN GLOBAL TRACK RECORD

In the last decade, our facilities and products have successfully passed inspections from all major regulatory authorities (FDA, EMA, PMDA (Japan), RP (Germany)).

80% COMPLEX, BIOLOGIC SUBSTANCES

Most of our partners’ compounds are sensitive biologic substances, including oligonucleotides, monoclonal antibodies, peptides, and more.


How we can support Asia’s biopharma sector

Locations in your market

The future of the biopharmaceutical industry is taking shape in Asia. We’re already there to help you create it. In addition to our main regional branch in Singapore, Vetter has growing teams in Japan and Korea and additional offices opening soon in China.


We’re ready to help you succeed

For more than 40 years, Vetter has provided leading cGMP manufacturing services for worldwide partners of every size – from science-driven startups to global commercial-stage organizations. Today, we’re excited to form and grow new partnerships with Asia’s innovative biopharma enterprises. We look forward to supporting yours.

Contact Vetter

Looking for expert manufacturing support for your product? Contact our dedicated Asia team today.

Get in touch